These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 988180)

  • 21. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF; Fernstrom JD
    Endocrinology; 1977 Aug; 101(2):469-74. PubMed ID: 560295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic administration does not alter the accumulation of L-dopa into muscle.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1994 Mar; 9(2):167-72. PubMed ID: 8196677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
    Lovinger R; Holland J; Kaplan S; Grumbach M; Boryczka AT; Shackelford R; Salmon J; Reid IA; Ganong WF
    Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-DOPA on endogenous histamine metabolism.
    Sharpless NS; Muenter MD; Tyce GM
    Med Biol; 1975 Apr; 53(2):85-92. PubMed ID: 1152552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
    Lindgren HS; Rylander D; Ohlin KE; Lundblad M; Cenci MA
    Behav Brain Res; 2007 Feb; 177(1):150-9. PubMed ID: 17157933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced ovulation in aged female rats by L-dopa implants into the medial preoptic area.
    Cooper RL; Brandt SJ; Linnoila M; Walker RF
    Neuroendocrinology; 1979; 28(4):234-40. PubMed ID: 571539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of hypothalamic dopamine into pituitary stalk blood of aged female rats.
    Reymond MJ; Porter JC
    Brain Res Bull; 1981 Jul; 7(1):69-73. PubMed ID: 7196793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of estrous cycles in old non-cyclic rats by progesterone, ACTH, ether stress or L-dopa.
    Huang HH; Marshall S; Meites J
    Neuroendocrinology; 1976; 20(1):21-34. PubMed ID: 180443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminergic and thermoregulatory mechanims in hypothalamic regulation of growth hormone in cats.
    Ruch W; Mixter RC; Russell RM; Garcia JF; Gale CC
    Am J Physiol; 1977 Jul; 233(1):E61-9. PubMed ID: 301705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Messiha FS
    Proc West Pharmacol Soc; 1977; 20():327-31. PubMed ID: 896840
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuropharmacological study on the induction of hypothalamic masculinization in female mice.
    Nishizuka M
    Neuroendocrinology; 1976; 20(2):157-65. PubMed ID: 986577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro occurrence of m-octopamine in the cultured cephalic ganglion of Locusta migratoria L. after L-dopa administration.
    Coulon JF; Lafon-Cazal M; David JC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(1):77-80. PubMed ID: 6146487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient shortening of estrous cycles in aging C57BL/6J mice: effects of spontaneous pseudopregnancy, progesterone, L-dihydroxyphenylalanine, and hydergine.
    Flurkey K; Randall PK; Sinha YN; Ermini M; Finch CE
    Biol Reprod; 1987 May; 36(4):949-59. PubMed ID: 3593860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.
    Kiessling M; Lindl T; Cramer H
    Arch Psychiatr Nervenkr (1970); 1975 Dec; 220(4):325-33. PubMed ID: 176961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No evidence for a peripheral effect of L-DOPA on plasma prolactin in the rat.
    Mattheij JA; Brouwer GM; Hanstede JG; Swarts JJ
    Life Sci; 1982 Aug; 31(9):915-21. PubMed ID: 7176820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.